Literature DB >> 28346089

A Chemogenomic Screening Platform Used to Identify Chemotypes Perturbing HSP90 Pathways.

Fiona M Thomas1, Kourtney M Goode1, Bartek Rajwa2, Andrew A Bieberich1, Larisa V Avramova2, Tony R Hazbun1,3, V Jo Davisson1,3.   

Abstract

Compounds that modulate the heat shock protein (HSP) network have potential in a broad range of research applications and diseases. A yeast-based liquid culture assay that measured time-dependent turbidity enabled the high-throughput screening of different Saccharomyces cerevisae strains to identify HSP modulators with unique molecular mechanisms. A focused set of four strains, with differing sensitivities to Hsp90 inhibitors, was used to screen a compound library of 3680 compounds. Computed turbidity curve functions were used to classify strain responses and sensitivity to chemical effects across the compound library. Filtering based on single-strain selectivity identified nine compounds as potential heat shock modulators, including the known Hsp90 inhibitor macbecin. Haploid yeast deletion strains (360), mined from previous Hsp90 inhibitor yeast screens and heat shock protein interaction data, were screened for differential sensitivities to known N-terminal ATP site-directed Hsp90 inhibitors to reveal functional distinctions. Strains demonstrating differential sensitivity (13) to Hsp90 inhibitors were used to prioritize primary screen hit compounds, with NSC145366 emerging as the lead hit. Our follow-up biochemical and functional studies show that NSC145366 directly interacts and inhibits the C-terminus of Hsp90, validating the platform as a powerful approach for early-stage identification of bioactive modulators of heat shock-dependent pathways.

Entities:  

Keywords:  Hsp90 C-terminal inhibitor; heat shock protein 90; high-throughput assay; phenotypic screen; target identification

Mesh:

Substances:

Year:  2017        PMID: 28346089      PMCID: PMC6521697          DOI: 10.1177/2472555216687525

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  35 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast.

Authors:  Ainslie B Parsons; Andres Lopez; Inmar E Givoni; David E Williams; Christopher A Gray; Justin Porter; Gordon Chua; Richelle Sopko; Renee L Brost; Cheuk-Hei Ho; Jiyi Wang; Troy Ketela; Charles Brenner; Julie A Brill; G Esteban Fernandez; Todd C Lorenz; Gregory S Payne; Satoru Ishihara; Yoshikazu Ohya; Brenda Andrews; Timothy R Hughes; Brendan J Frey; Todd R Graham; Raymond J Andersen; Charles Boone
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

Review 3.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

4.  Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone.

Authors:  Rongmin Zhao; Mike Davey; Ya-Chieh Hsu; Pia Kaplanek; Amy Tong; Ainslie B Parsons; Nevan Krogan; Gerard Cagney; Duy Mai; Jack Greenblatt; Charles Boone; Andrew Emili; Walid A Houry
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

5.  Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization.

Authors:  Rudi K Allan; Danny Mok; Bryan K Ward; Thomas Ratajczak
Journal:  J Biol Chem       Date:  2006-01-17       Impact factor: 5.157

6.  Characterization of Hsp70 binding and nucleotide exchange by the yeast Hsp110 chaperone Sse1.

Authors:  Lance Shaner; Rui Sousa; Kevin A Morano
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

7.  Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay.

Authors:  Nadine C Gassner; Craig M Tamble; Jonathan E Bock; Naomi Cotton; Kimberly N White; Karen Tenney; Robert P St Onge; Michael J Proctor; Guri Giaever; Corey Nislow; Ronald W Davis; Phillip Crews; Theodore R Holman; R Scott Lokey
Journal:  J Nat Prod       Date:  2007-02-10       Impact factor: 4.050

8.  Synthesis of novel fluorescent probes for the molecular chaperone Hsp90.

Authors:  Laura Llauger-Bufi; Sara J Felts; Henri Huezo; Neal Rosen; Gabriela Chiosis
Journal:  Bioorg Med Chem Lett       Date:  2003-11-17       Impact factor: 2.823

9.  Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates sensitivity to the Hsp90 inhibitor radicicol.

Authors:  Stefan H Millson; Andrew W Truman; Attila Rácz; Bin Hu; Barry Panaretou; James Nuttall; Mehdi Mollapour; Csaba Söti; Peter W Piper
Journal:  FEBS J       Date:  2007-08-06       Impact factor: 5.542

10.  A Simple Chemical Method for Rendering Wild-Type Yeast Permeable to Brefeldin A That Does Not Require the Presence of an erg6 Mutation.

Authors:  Vanesa G. Pannunzio; Hilda I. Burgos; Manuel Alonso; James R. Mattoon; Eugenia H. Ramos; Carlos A. Stella
Journal:  J Biomed Biotechnol       Date:  2004
View more
  1 in total

Review 1.  Chemical Screening of Nuclear Receptor Modulators.

Authors:  Mari Ishigami-Yuasa; Hiroyuki Kagechika
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.